Given that DSCAM-AS1 is an ER-regulated lncRNA, correlation was performed using only ER-positive breast cancers, to ascertain clinical relevance in the breast cancer samples in which DSCAM-AS1 would be enriched and most relevant. This evidence concerns the gene DSCAM and breast cancer.